Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | May 1, 2010 |
| Phase: | Phase I|Phase II |
| Status: | Recruiting |
| NCT ID: | NCT01064648 |
| Study Type: | Interventional |
| Intervention: | Drug: cediranib maleate|Drug: cisplatin|Drug: pemetrexed disodium|Other: placebo |
| Study Design: | Allocation: Randomized|Control: Placebo Control|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Southwest Oncology Group|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 116 |
| Funded By: | Other|NIH |
| First Received: | February 5, 2010 |
| End Date: | |
| Last Updated: | October 14, 2010 |
| Last Verified: | October 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
